Melanoma Institute Australia

Hervey Bay Half Marathon Festival 2026
2026-06-21 | WA
The Hervey Bay Half Marathon Festival offers runners a truly unique coastal experience, set against the stunning backdrop of Queensland’s Fraser Coast. With sweeping ocean views, tranquil beaches, and an inviting esplanade lined with palms and cafés, participants will be immersed in the laid-back charm and natural beauty of this coastal paradise.
Whether you’re chasing a personal best or simply soaking up the scenery, the course makes the perfect setting for all types of runners—from seasoned athletes to first-timers.
With a variety of distances on offer — Half Marathon – 21.1km | 10km | 5km run & 5km walk | 2km Fun Run & Walk — there’s something for everyone to experience the excitement of crossing the finish line along Hervey Bay’s iconic foreshore.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

ASCO Breakthrough
2026-06-25 - 2026-06-27 | Raffles City Convention Centre, 80 Bras Basah Road, Singapore, 189560, Singapore
ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering novel research and expert, multidisciplinary perspectives on the newest scientific findings, clinical and technology advances, and treatment approaches that are rapidly changing cancer care. Take part in insightful sessions, case discussions, and abstract presentations, and join a community of like-minded professionals to contribute, together, toward conquering cancer.
Why Attend ASCO Breakthrough?

Access Global Science with Regional Perspectives
Connect with the Global ASCO Community in Asia
Gain Insight to Enhance Your Clinical Practice

Program Overview
Sessions will cover a range of topics, including:

Confronting the Global Surge of Early-Onset Cancers
A Discussion on What It Will Take to Make Clinical Artificial Intelligence a Reality at the Bedside
Antibody-Drug Conjugates
New Immunotherapy Combination Strategies
Minimal Residual Disease in 2026 and What Is On The Horizon
Advancing Equitable Oncology in the Asia-Pacific Region – Bridging Gaps With Common Sense
Case-Based Sessions focused on Liver Cancer, Cervical Cancer, and Oral Cavity Cancers

The Program will also include scientific update sessions, the presentations of new and novel scientific advances, and opportunities for attendees to network and connect with each other to build meaningful partnerships.
Location: Raffles City Convention Centre, Singapore
Key Dates:
Conference dates: 25 – 27 June, 2026
Early registration deadline: 20 May, 2026 at 11:59 PM (ET)
FIND OUT MORE

SHP Pilot Grants
2026-07-03 17:00 (Australia/Sydney) | WA
SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice
Each year, Sydney Health Partners funds pilot projects that help clinicians, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact.
If you’re a health professional, clinician, or researcher leading research within Sydney Health Partners’ affiliated health services, a Pilot Grant could help you to:

Test real-world implementation of research innovations
Solve complex health system challenges with practical solutions
Strengthen applications for major funding bodies (NHMRC, MRFF, TRGS)

Applications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants.
Sydney Health Partners are offering up to $220,000 in grants to support up to 11 pilot projects, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund.
Grant Categories:
Stream 1: SHP Implementation Science Pilot Grants (up to 9)
These grants require two Principal Investigators (PIs):

One from the University of Sydney or an SHP Partner Medical Research Institute (MRI)

One from an SHP Health Service Partner

Stream 2: CPC Implementation Hub Pilot Grants (x2)
These grants require two PIs – One must be a member of the Charles Perkins Centre:

One must be a University of Sydney or SHP Partner MRI employee

One from an SHP Health Service Partner

Key Dates:
Applications close: 3 July 2026, 5:00pm AEST
Successful applicants will be notified: August 2026
Grants will commence: from January 2027
SEE GRANT GUIDELINESSEE WEBSITE

RACP Research Awards and Career Grants
2026-07-07 17:00 (Australia/Sydney) | WA
Through the RACP Foundation, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships, scholarships and grants are available annually, totalling over $2.5 million in funding.
Career Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships.
Research Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career.
Research Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are:

at the start of their research careers and about to enrol in a Masters, PhD or equivalent research higher degree
in the 1st or 2nd full-time equivalent year of their research degree.

Key Dates
Applications close: 30 June 2026
Applications close (Research Entry Scholarships): 7 July 2026
Outcomes advised: December 2026
SEE WEBSITE

NSW Premier's Awards for Outstanding Cancer Research
2026-07-13 12:00 (Australia/Sydney) | WA
The Cancer Institute NSW is delighted to announce the return of the NSW Premier’s Awards for Outstanding Cancer Research, a prestigious event that pays tribute to the remarkable accomplishments of individuals and teams within the cancer research community and those supporting innovation and cutting-edge delivery of care.
Now is your chance to nominate an exceptional team or individual. The Outstanding Cancer Clinical Trials Unit Award is especially relevant to your work.
This Award recognises a high-performing cancer clinical trials unit in New South Wales that demonstrates operational excellence, leadership in trial conduct, and commitment to advancing access to cancer clinical trials.
Nominations are now open across nine award categories:
• Outstanding Cancer Researcher of the Year Award
• Outstanding Early Career Researcher Award
• Outstanding Mid-Career Researcher Award
• Rising Star PhD Candidate Award
• Outstanding Cancer Clinical Trials Unit Award
• Consumer Engagement in Cancer Research Award
• Cancer Control Innovation Award
• Improving Equitable Outcomes through Cancer Research Award
• Reducing Cancer Inequality for Aboriginal People Award
These categories highlight progress and success in line with the strategic goals of the NSW Cancer Plan and NSW Aboriginal Cancer Strategy.
The winners will be announced at the NSW Premier’s Awards for Outstanding Cancer Research event to be held at 5.00pm Thursday 19 November 2026 at NSW Parliament House.
Anyone involved in improving cancer patient outcomes within NSW is eligible to be nominated.
Key date:
Nominations close 12pm (noon) Monday 13 July 2026.
SEE GRANT GUIDELINESSEE WEBSITE

MPA-MIA Community Webinar Series 2026
2026-07-14 - 2026-07-28 | WA
Join us for an informative series of three live webinars for patients with melanoma and their carers.
Hosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA), each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion.
The webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend.
Note that the webinars are held from 7pm to 8pm AEST.
Cost: Free
Webinar One: ‘Your melanoma nurse: What they do and how they help’
When: Tuesday 14 July | 7 – 8pm AEST
Speakers:

Rebecca Johnson – National Melanoma Nurses Program Manager
Peta Holly – Specialist Melanoma Telehealth Nurse
A community member

REGISTERWebinar Two: ‘Understanding endocrine side effects of immunotherapy’
When: Tuesday 21 July | 7 – 8pm AEST
Speakers:

Dr Stephanie Zunder – Medical Oncologist
Dr Annabel Hayes – Endocrinologist
Aled Gaynor – Medical Oncology Clinical Nurse Consultant
A community member

REGISTERWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’
When: Tuesday 21 July | 7 – 8pm AEST
Speakers:

A/Prof Alexander van Akkooi – Surgical Oncologist
Shahn Coburn – Surgical Clinical Nurse Consultant
A community member

REGISTER

MRFF National Critical Research Infrastructure
2026-07-14 17:00 (Australia/Sydney) | WA
The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.
Stream 1 – Innovation enablers
Address an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel platforms, and secure health data environments to create valuable research resources.
Stream 2 – Digitisation of health care
Translate or implement innovative artificial intelligence technologies into health applications that:

benefit multiple health disciplines/areas
involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and
increase artificial intelligence workforce capacity and capability, particularly in relation to health, through cross-sector and interdisciplinary collaboration.

Stream 3 – Co-investment partnerships
Utilise co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment):

to support development of research capacity, capability and/or effectiveness in an area of unmet medical need, or
to enable Australian research using new platforms, systems and services in an area of unmet medical need.

Stream 4 – mRNA technology enablers
Leverage and enhance emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.
Grants to fund research infrastructure projects, up to $3 million in Streams 1, 2 and 4, and up to $7 million in Stream 3.
An application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application.

Key Dates
Applications close: 14 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF BioMedTech Incubator
2026-07-22 17:00 (Australia/Sydney) | WA
The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators.
This grant is for an eligible organisation who can establish a working incubator, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development.
The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative.
This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential.
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation.
Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector).
Grants of up to $33 million to establish BioMedTech Incubators.

Key Dates
Applications close: 22 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

ASDR Annual Scientific Meeting
2026-07-23 - 2026-07-25 | Westmead Innovation Centre, Hawkesbury Rd, Sydney, NSW, 2145, Australia
The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre, Sydney, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include:

Keratinocyte and Squamous Cell Carcinomas
Melanocyte/ Keratinocyte biology
Microenvironment
Fundamental Skin Research
Skin immunology and immune disorders
Autoimmune Disorders
Wound Healing and Stem Cells
Melanoma and Pigmentation Disorders
Skin Translational Research

We look forward to bringing together researchers, clinicians, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research.
Location: Westmead Innovation Centre, Sydney, Australia
Key Dates:
Abstract Submission Deadline: 19 April 2026
Abstract Outcomes: 15 May 2026
Early Bird Registration Deadline: 30 June 2026 at 23:59 AEST
Registration Deadline: 16 July 2026 at 23:59 AEST
FIND OUT MORE

Plastic Surgery Congress 2026
2026-07-24 - 2026-07-25 | Sofitel Brisbane Central, 249 Turbot Street, Brisbane, QLD, 4000, Australia
Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC), where the future of plastic, reconstructive, and aesthetic surgery takes centre stage.
​Taking place at the Sofitel Brisbane Central, PSC 2026 promises a dynamic program packed with cutting-edge content, world-class presentations, and the latest global best practices. With two full days of medical education, hands-on workshops, and lively social events, the Congress is designed to spark collaboration and professional growth.
​In 2026, delegates can expect an exceptional line-up of international and local faculty, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus, featuring topics not previously explored in depth at past congresses. These include burns, peroneal reconstruction, hands and brachial plexus surgery, and aesthetics. And of course, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer.
​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today.
​Key Dates
Abstracts close: 9 February 2026
Early bird registration closes: 22 April 2026
Congress Venue
Sofitel Brisbane Central
249 Turbot Street Brisbane QLD 4000 AUSTRALIA​
​
FIND OUT MORE

SHP Annual Forum
2026-07-29 | Kerry Packer Education Centre, John Hopkins Drive, Camperdown, NSW, 2050, Australia
Program details and registration coming soon.
Location: Kerry Packer Education Centre, The University of Sydney, Camperdown
Key Date: Wednesday 29 July 2026
FIND OUT MORE

NHMRC Investigator Grants
2026-07-29 17:00 (Australia/Sydney) | WA
Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package.
In this way, the Chief Investigator has flexibility to pursue important new research directions as they arise, adjust their resources accordingly, and to form collaborations as needed, rather than being restricted to the scope of a specific research project.
Investigator Grants support:

Research across the 4 pillars of health and medical research: biomedical, clinical, public health and health services research.
All career stages: early career researchers, mid-career researchers and established researchers
Researchers with clinical responsibilities (such as clinicians, public health and allied health practitioners)
Full-time and part-time researchers.

Investigator Grants aim to:

Allow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed
Foster innovative and creative research
Create opportunities for researchers at all career stages to establish their own research programs
Reduce application and peer review burden on researchers.

Key Dates:
Applications open: 3 June 2026
Minimum data due: 1 July 2026
Applications close: 29 July 2026
Proposed peer review: August – November 2026
Outcomes to be advised: March 2027
SEE GRANT GUIDELINESSEE WEBSITE

MOGA Annual Scientific Meeting
2026-08-05 - 2026-08-07 | RACV Royal Pines Resort, Ross Street, Gold Coast, Queensland, 4217, Australia
The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme:
Reimagining Cancer Care: Is Less Doing More?
In recent years, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology, immunotherapy, molecular profiling, and patient-centred care, we are beginning to ask a powerful and, at times, uncomfortable question: Are we sometimes doing too much?
We are now confronting the possibility that treatment de-escalation is not just a compromise, but potentially a pathway to more humane, precise, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy, shared decision-making, and what quality of life truly means in the era of personalised medicine.
This ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology, to palliative care and psychosocial support. We will consider not only clinical evidence, but also the ethical, logistical, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science, but through listening.
Location: RACV Royal Pines, Gold Coast, Australia
Key Dates:
Early Bird Registrations Close: 14 June 2026
Abstract Submissions Close: 14 June 2026
Abstract Selection Advice: 3 July 2026
Abstract Acceptance by Presenter: 10 July 2026
Travel Award Applications Open: 3 July 2026
Travel Award Applications Close: 10 July 2026
Travel Award Recipient Notification: 17 July 2026
FIND OUT MORE

MRFF Genomics Health Futures
2026-08-19 17:00 (Australia/Sydney) | WA
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
Stream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy.
Stream 2 (TCR): conduct scalable research to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies.
Stream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease, diabetes and other common and/or complex diseases).
Stream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer, colorectal cancer, prostate cancer and other common cancers)
Stream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice.
Stream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing, portability, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics.
Applicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan.
Key Dates

Minimum data due date: 22 July 2026
Applications close: 19 August 2026
Indicative funding status: Funding anticipated to be awarded from June 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
2026-08-19 17:00 (Australia/Sydney) | WA
The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers.
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct early stage, small scale research, led by early career researchers, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.
Stream 2 (Accelerator): establish a large-scale interdisciplinary research program, led by mid-career researchers, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.
Stream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).

The intended outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.
Stream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.
Stream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.

Key Dates:
Minimum data due: 22 July 2026
Applications close: 19 August 2026
Grant activity timeframe: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

2026 TCS Sydney Marathon presented by ASICS
2026-08-30 | WA
Whether you’re chasing your debut or your next star, the TCS Sydney Marathon presented by ASICS is your moment to shine.
Sydney is the bucket-list race that redefines what’s possible, so come experience the place where the world comes to finish.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

European Congress of Pathology
2026-09-12 - 2026-09-16 | Stockholmsmässan, Mässvägen 1, Älvsjö, 12530, Sweden
The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026), to be held at Stockholmsmässan, from 12 –16 September 2026, in the heart of Sweden’s capital.
ECP 2026 will bring together more than 5,000 participants from all over the world—pathologists, clinicians, researchers, molecular biologists, bioinformaticians, medical scientists, and industry partners. The meeting will provide an ideal opportunity for professional development, networking, to exchange insights, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future.
The motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups, ESP-affiliated societies, education and trainee committees, and other collaborating societies will include keynote lectures, slide seminars, symposia, and interactive workshops, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology, AI integration, and emerging technologies that are transforming our field.
Location: Stockholmsmässan, Stockholm, Sweden
Key Dates:
Abstract submission deadline: 8 April 2026
Abstract notifications: early June 2026
Registration and payment deadline for authors of accepted abstracts: 25 June 2026
FIND OUT MORE

ABNA Annual Conference
2026-09-16 - 2026-09-18 | Crowne Plaza Hobart, 110 Liverpool Street, Hobart, Tasmania, 7000, Australia
ABNA’s Annual Conference “From Collection to Discovery: Enabling Research, Accelerating Impact” will be held in Hobart, 16-18 September 2026.
The star event in the annual ABNA calendar, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology.
Enjoy workshops, special interest group meetings, rapid fire presentations, poster displays, and elevator pitch presentations as well as a range of networking events including biobanker speed networking, a site visit and gala dinner to facilitate collaborations with researchers, policymakers, corporate sponsors and industry leaders to drive innovation and partnership.
Don’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there!
Location: Crown Plaza Hobart, Tasmania
Key Dates:
Abstract submission deadline: 14 August 2026
Abstract notifications: late August/early September 2026
Early bird registration deadline: 31 July 2026
FIND OUT MORE

MRFF International Clinical Trial Collaborations
2026-09-16 17:00 (Australia/Sydney) | WA
The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

The anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.
Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only.

Key Dates:
Minimum data due: 19 August 2026
Applications close: 16 September 2026
SEE GRANT GUIDELINESSEE WEBSITE

IAP Congress
2026-10-08 - 2026-10-13 | Fukuoka International Congress Center, 2-1 Sekijōmachi, Fukuoka, 8120032, Japan
It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements, challenges, and debates in diagnostic and molecular pathology are shared and discussed.
This biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology, which is held annually in Japan.
As the theme of this year’s congress is “Vision for the Future”, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases.
Location: Fukuoka International Congress Center, Fukuoka Sunpalace, Fukuoka, Japan
Key Dates:
Abstract Submission Deadline: Friday 10 April 2026, 17:00 (JST)
Young Pathologist Award Application & Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Abstract Submission: Friday 10 April 2026, 17:00 (JST)
IAP Bursary Application Deadline: Thursday 30 April 2026
Notification of Acceptance: June 2026
FIND OUT MORE

CDMRP Melanoma Research Program
2026-10-14 17:00 (America/Halifax) | WA
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities:

· Focused Program Award – Rare Melanomas
This award supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.
· Idea Award
The Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
· Melanoma Academy Scholar Award
Supports the addition of independent, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful, highly productive melanoma researchers in a collaborative research and career development environment.
· Survivorship Research Award
The award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.
· Team Science Award
Supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes.
Key Dates:
Submission Deadline (Pre-application-Pre-Proposal): 13 July 2026
Focused Program Award – Rare Melanomas
Idea Award
Team Science Award
Submission Deadline (Pre-application-Pre-Proposal): 22 September 2026
Melanoma Academy Scholar Award
Survivorship Research Award
Application Submission Deadline: 14 October 2026

SEE GRANT GUIDELINESSEE WEBSITE

ESMO Congress
2026-10-23 - 2026-10-27 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care. Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
A comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives:

To stay informed about current approaches in cancer prevention, screening, and early detection
To gain insights into the latest advances in basic, translational, and clinical cancer research
To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
To be updated on state-of-the-art therapeutic strategies for patients with cancer
To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy

Location: IFEMA Madrid, Madrid, Spain
Key Dates:
Early Registration Deadline: 22 July 2026 at 23:59 CEST
Abstract Submission Deadline: 12 May 2026 at 21:00 CEST
Late-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST
Conference Dates: 23 October 2026 – 27 October 2026
FIND OUT MORE

ESSO Congress
2026-11-04 - 2026-11-06 | IFEMA Madrid, Avda. Del Partenon, 5, Madrid, 28042, Spain
The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care.
Bringing together oncology surgeons, researchers, and healthcare professionals from across the globe, the ESSO Congress offers a dynamic platform for sharing cutting-edge research, surgical innovations, and multidisciplinary approaches to cancer treatment.
With a strong focus on education, collaboration, and excellence in patient outcomes, the congress fosters dialogue, drives progress, and shapes the future of surgical oncology.
With the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide, we will explore the latest advancements, global perspectives, and shared challenges that shape the future of Surgical Oncology around the world.
Location: IFEMA Madrid, Spain
Key Dates:
Abstract submission deadline: 6 May 2026
Abstract review results: 6 July 2026
Early registration deadline: 19 August 2026
FIND OUT MORE

SITC Annual Meeting
2026-11-04 - 2026-11-08 | Phoenix Convention Center, 100 N 3rd Street, Phoenix, AZ, United States
SITC 2026 is the premier international conference focused on cancer immunotherapy, bringing together leaders from academia, regulatory agencies, government, and industry for education, scientific exchange, and networking.
The conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy.
Why attend SITC 2026?

Cutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)
In-person networking opportunities with IO luminaries
Access the latest immuno-oncology research

Location: Phoenix Convention Center, Phoenix, Arizona, United States
Key Dates:
Regular and early career investigator award abstract submission deadline: 25 June 2026
Abstract notifications: 31 July 2026
Late-breaking abstract submission deadline: 10 September 2026
Abstract notifications: 28 September 2026
FIND OUT MORE

IPOS Annual World Congress
2026-11-09 - 2026-11-12 | Hotel Barceló Sants, Pl. dels Països Catalans, s/n, Sants-Montjuïc, Barcelona, 08014, Spain
The annual IPOS World Congress of Psycho-Oncology and Psychosocial Academy brings together professionals in diverse fields from around the globe who dialogue about improving cancer care on an international level and developing strategies to add psychosocial issues to all aspects of cancer control. The attendees include, but are not limited to, psychologists, psychiatrists, physicians, nurses, social workers, social scientists, patient advocates, educators and administrators, dieticians, epidemiologists, spiritual care specialists, and vocational rehabilitation specialists.
The congress offers three days of symposia, podium presentations and posters addressing a variety of disciplines within cancer supportive care. The congress is held in conjunction with the Psychosocial Academy which offers one day of training workshops and presentations.
The theme of the congress is «Towards a sustainable psycho-oncology: of all and for all». In the twenty-first century, there is no longer any doubt about the need to address the psychological aspects of cancer patients and their families, nor about the necessity of incorporating it in patient care throughout the entire cancer journey. It is time to make psycho-oncology a reality across the entire healthcare and social support network for people living with cancer all over the world.

Location: Hotel Barceló Sants, Barcelona, Spain

Key Dates:
Abstract Submission Deadline: 15 July 2026
Abstract Decision Notification: August 2026
Presenting Author Registration and Payment Deadline: 1 October 2026
Workshop Submission Deadline: 1 July 2026
Early Bird Registration Deadline: 11 August 2026
FIND OUT MORE

COSA Annual Scientific Meeting
2026-11-11 - 2026-11-13 | ICC Sydney and Cockle Bay – Darling Harbour, 14 Darling Dr, Sydney, NSW, 2000, Australia
We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026, with pre-conference workshops being held on Tuesday 10 November.
The theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care.

This theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach, to care that is increasingly tailored to the individual, across the entire cancer journey.
The disease theme will have a strong focus on lung cancers, alongside sessions addressing head and neck cancers, early-onset cancers such as colorectal cancer, and brain cancer, including both primary and metastatic disease. As always, equity will be embedded throughout the program, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer.
It has been almost a decade since the COSA ASM was held in Sydney, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time, including the molecular biomarker realm and the evolution of novel transformative therapeutics.
Australia has developed deep expertise across clinical care, research and clinical trials, implementation and policy, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development, precision oncology, pharmacogenomics and palliative and supportive care.

Location: International Convention Centre (ICC), Sydney, Australia
Key Dates:
Delegate Designed Symposia Submissions Close: 3 July 2026
Abstract Submissions Close: 7 August 2026
Abstract Decision Notification: 2 September 2026
Abstract Acceptance by Presenter: 11 September 2026
Early Bird Registration Deadline: 11 September 2026
Pre-conference Workshops: 10 November 2026
FIND OUT MORE

NHMRC Partnership Projects
2026-11-11 17:00 (Australia/Sydney) | WA
The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions, undertake research, interpret the findings and implement the findings into policy and practice.

Partnership Projects create partnerships among decision makers, policy makers, managers, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery, organisation, funding and access to health services.
Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.
The objectives of the Partnership Project scheme are to:
• Meet the need for more effective integration of research evidence into health policy and service delivery
• Create partnerships among policy makers, managers, service providers and researchers
• Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care
• Be highly responsive to the priorities of government, the community and health professionals
• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

Key Dates for Peer Review Cycle 2:
Applications open: 19 March 2026
NHMRC-approved Administering Institutions waiver due: 8 July 2026
Minimum data due: 22 July 2026
Applications close: 5 August 2026
Peer review meetings: 17-19 November 2026
Key Dates for Peer Review Cycle 3:
Applications open: 23 July 2026
NHMRC-approved Administering Institutions waiver due: 14 October 2026
Minimum data due: 28 October 2026
Applications close: 11 November 2026
Peer review meetings: 2-4 March 2027
SEE GRANT GUIDELINESSEE WEBSITE

Australasian Melanoma Conference
2026-11-19 - 2026-11-21 | Sofitel Melbourne on Collins, 25 Collins Street, Melbourne, Victoria, 3000, Australia
The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research, diagnosis, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians, researchers, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration.
The AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of:

Prevention
Early Detection
Advanced Diseases
Survivorship

Location: Sofitel Melbourne on Collins, Melbourne, Australia
Key Dates:
Conference Dates: 19 November 2026 – 21 November 2026
Early Bird Registration Deadline: 31 July 2026
Abstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST)
FIND OUT MORE

Melanoma and Immunotherapy Bridge
2026-11-30 - 2026-12-03 | Royal Continental Hotel Naples, Via Partenope 38/44, Naples, 80121, Italy
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 11th edition of Immunotherapy Bridge and the 16th edition of Melanoma Bridge will be held in Naples (Italy) from November 30th to December 1st and from December 1st to 3rd, respectively.
The first session of Immunotherapy Bridge will be jointly organized with the Society for ImmunoTherapy of Cancer and dedicated to the Modulator of Tumor Immunity and Immunotherapy. An in depth analysis of the drivers of organ specific immune response, the novel drugs development, the actual landscape and future perspectives on the field of cancer vaccines and the neoadjuvant therapies across cancers will follow.
The scientific program of Melanoma Bridge will be dedicated to the most pressing of the unanswered questions, the translational research in melanoma and the most valuable emerging strategies.
Both Immunotherapy and Melanoma Bridge meetings will host a “Great Debate” session, where counterpoint views from leading experts on specific controversial clinical issues will be presented, discussed and evaluated by the audience.

Location: Royal Continental Hotel Naples, Italy

Key Dates
Abstract Submission Deadline: 5 October 2026
Abstract Decision Notification: 30 October 2026
FIND OUT MORE

ASI Annual Scientific Meeting
2026-11-30 - 2026-12-04 | QT Canberra, 1 London Cct, Canberra, 2601, Australia
The ASI 2026 Local Organising Committee warmly invites you to join us for the 54th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology (ASI), to be held 30 November – 4 December 2026 in Canberra (Ngunnawal Country), Australia’s national capital.
Set in one of the world’s most sustainable and liveable cities, Canberra offers the perfect setting for a week of discovery, connection, and scientific excellence. Our comprehensive program will spotlight the leading immunological research from Australia, New Zealand and around the world. The program will include a wide range of topics covering cutting-edge fundamental, translational, and clinical immunology—from infection, inflammation, and autoimmunity to tumour immunology, and immunometabolism.
Our meeting venue, QT Canberra, provides an intimate environment designed to support vibrant discussion and collaboration. Set close to the city centre, on the shores of Lake Burley Griffin, you will be within easy reach to a thriving food and wine scene, national museums and galleries and scenic outdoor spaces providing every opportunity to immerse yourself in the best Canberra has to offer.
We look forward to welcoming you to ASI 2026 in Canberra—a meeting that promises rich scientific exchange, renewed connections, and an engaging celebration of our immunology community.

Location: QT Canberra, Canberra, Australia
Key Dates:
Abstract Submission Deadline: mid-late August 2026
Abstract Decision Notification: Sep – Oct 2026
Early Bird Registration Deadline: mid-late August 2026
Standard Registration Deadline: 23 November 2026

FIND OUT MORE
